Edwards Lifesciences (EW) Capital Expenditures Growth (1y) (2010 - 2026)
Edwards Lifesciences (EW) Capital Expenditures Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | -1.00% |
| 2 | Stryker | 127.04 Bn | 123.56 Bn | 4.50 Bn | 10.38% |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | 24.20% |
| 5 | Edwards Lifesciences | 52.03 Bn | 47.78 Bn | 1.35 Bn | 35.70% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | -9.99% |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 16.28% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -4.32% |
| 9 | Steris | 23.03 Bn | 22.54 Bn | 684.20 Mn | -6.52% |
| 10 | Zimmer Biomet Holdings | 19.18 Bn | 18.77 Bn | 1.54 Bn | 8.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.70% |
| Mar 31, 2026 | 15.89% |
| Dec 31, 2025 | 95.58% |
| Sep 30, 2025 | 10.79% |
| Jun 30, 2025 | -42.27% |
| Mar 31, 2025 | -14.24% |
| Dec 31, 2024 | -43.60% |
| Sep 30, 2024 | -6.15% |
| Jun 30, 2024 | 78.29% |
| Mar 31, 2024 | 6.18% |
| Dec 31, 2023 | 28.16% |
| Sep 30, 2023 | -7.68% |
| Jun 30, 2023 | 11.14% |
| Mar 31, 2023 | -15.41% |
| Dec 31, 2022 | -23.27% |
| Sep 30, 2022 | -1.32% |
| Jun 30, 2022 | -37.81% |
| Mar 31, 2022 | -31.42% |
| Dec 31, 2021 | -20.67% |
| Sep 30, 2021 | -41.24% |